These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 936380)

  • 1. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
    Susan LP; Roth RB; Adkins WC
    Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone-induced activation of fibrinolysis in carcinoma of the prostate.
    Rosswick RP
    Br J Urol; 1967 Apr; 39(2):143-6. PubMed ID: 6025389
    [No Abstract]   [Full Text] [Related]  

  • 3. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
    Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
    Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
    Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.
    Band PR; Banerjee TK; Patwardhan VC; Eid TC
    Can Med Assoc J; 1973 Oct; 109(8):697-9. PubMed ID: 4746128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient with carcinoma of the prostate in treatment with stilphosterol developed a near fatal pulmonary complication.
    Jones WL
    S D J Med; 1982 May; 35(5):5-8. PubMed ID: 6955947
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombocytopenia during diethylstilbestrol diphosphate (stilphostrol) infusion for carcinoma of the prostate.
    Nachtsheim DA; McPherson RA; Pollen JJ; Schmidt JD
    Prostate; 1980; 1(1):105-9. PubMed ID: 7279796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
    Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
    Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy.
    Goldenberg SL; Fenster HN; Perler Z; McLoughlin MG
    Urology; 1983 Aug; 22(2):130-2. PubMed ID: 6879882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose intravenous oestrogen (fosfestrol) in the treatment of symptomatic, metastatic, hormone-refractory carcinoma of the prostate.
    Ahmed M; Choksy S; Chilton CP; Munson KW; Williams JH
    Int Urol Nephrol; 1998; 30(2):159-64. PubMed ID: 9607886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of hormone therapy to bone metastatic prostate cancer.
    Wakisaka M; Nomura K
    Int J Urol; 2006 May; 13(5):550-4. PubMed ID: 16771724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of metastasizing prostate carcinoma with special reference to the bioavailability of fosfestrol after oral administration].
    Oelschläger H; Rothley D; Dunzendorfer U
    Arzneimittelforschung; 1988 Oct; 38(10):1502-12. PubMed ID: 3058134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol: correlation of response to the in vitro synthesis of RNA by patient lymphocytes and its relationship to transcortin.
    Narasimhan P; Amaral L
    Am J Hematol; 1980; 8(4):369-75. PubMed ID: 7416164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow metastases from prostatic cancer-marked cytolytic effect after only a few days of treatment with diethylstilbestrol.
    Bjøorneklett A; Stavem P; Ly B; Egeberg O
    Scand J Haematol; 1976 Sep; 17(3):227-30. PubMed ID: 968453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androgen-independent prostate cancer with bone metastasis successfully treated by intravenous administration of zoledronic acid and diethylstilbestrol diphosphate].
    Nishizawa S; Yamauchi T; Sawada Y
    Hinyokika Kiyo; 2007 Dec; 53(12):891-5. PubMed ID: 18203529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.
    Citrin DL; Elson P; Kies MS; Lind R
    Am J Med; 1984 May; 76(5):787-93. PubMed ID: 6539069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive jaundice associated with carcinoma of the prostate.
    Ben-Ishay D; Slavin S; Levij IS; Eliakim M
    Isr J Med Sci; 1975 Aug; 11(8):838-44. PubMed ID: 1165179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Honvan-high-dose therapy of prostatic carcinoma with metastases: early complications and value of prophylaxis against thrombosis].
    Heinz A; Meyer WW; Hallwachs O
    Urologe A; 1982 Jul; 21(4):232-4. PubMed ID: 6890263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.